Sa1744 Utility and Safety of Endoscopic Submucosal Dissection for Duodenal Tumors

      Endoscopic submucosal dissection (ESD) was developed as an endoscopic treatment for early gastric cancer, but it is now also used in the esophagus and colon. However, ESD in the duodenum is considered more difficult because of poor scope maneuverability and a high rate of perforation and bleeding. Therefore, the evidence on efficacy of ESD for duodenal tumors is still limited. The aim of this study was to assess the utility and safety of ESD for duodenal tumors.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect